You are on page 1of 51

SURVIVING SEPSIS CAMPAIGN

INTERNATIONAL GUIDELINES FOR


MANAGEMENT OF SEPSIS AND SEPTIC
SHOCK 2021 .
A COMPARISON WITH 2016 GUIDELINES.

DR. MANISH JAGIA


(HOD, ANAESTHESIA AND CRITICAL CARE)
DR. CHHAVI TECKCHANDANI
(ATTENDING CONSULTANT,ANAESTHEISA)
SEPSIS AND SEPTIC SHOCK
DEFINITIONS
• Sepsis is defined as Life threatening organ
dysfunction caused by dysregulated host response
to infection. (3rd international consensus definition )
• Septic shock is a subset of sepsis in which
underlying circulatory and cellular/ metabolic
abnormalities are profound enough to substantially
increase mortality.
• Critical imbalance between oxygen supply and
demand.
• Patients with septic shock can be generally
identified with a clinical construct of sepsis with
persisting hypotension requiring vasopressors to
maintain MAP >65 mmhg and having serum lactate
levels >2 mmol/l despite adequate volume
resuscitation .
• With these criteria, hospital mortality exceeds 40%
( NCBI, 3RD international consensus definition for
sepsis, septic shock. )
GUIDELINES
• Screening and early treatment
• Screening tools for patients with sepsis and
septic shock
• Measurement of lactate levels
• Initial resuscitation
• Target mean arterial pressures
• Admission to ICU
• Infection control
 Antimicrobial therapy – antibacterial, antifungal,
antiviral therapy.
 to start antibiotics
 Patients with MRSA infection

• Hemodynamic measurement
• Ventilation
• Additional therapies
• Long term outcomes and goals of care
TERMINOLOGIES
• RECOMMENDATION- strong, moderate, weak
• EVIDENCE QUALITY - High, moderate, low
• RECOMMENDATION- for, against
• SUGGESTION- for, against
SCREENING AND EARLY
TREATMENT
2021 GUIDELINES 2016 GUIDELINES
It is RECOMMENDED that for acutely SEPSIS SCREENING (strong
ill, high risk patients , Performance recommendation, moderate quality
improvement programme for sepsis
evidence ) alone is
which includes both
RECOMMENDED as a
SEPSIS SCREENING (strong Performance improvement
recommendation, moderate quality programme for acutely ill, high risk
evidence )
patients
STANDARD OPERATING
PROCEDURES ( strong
recommendation, low quality
evidence )
Should be used for treatment.
SEPSIS SCREENING STANDARD OPERTAING
TOOLS PROCEDURE

• Screening tools are set of • Set of practices that specify


screening parameters which a preferred response to
help to identify sepsis early. specific clinical
• Sepsis screening, Education. circumstances .
• In any locations of the • Initially identified as GOAL
hospital- Emergency DIRECTED THERAPY,
department, wards, OTs, now evolved to usual care
ICUs. • Lactates, cultures,
antibiotics, fluids.
SCREENING TOOLS FOR PATIENTS
WITH SEPSIS AND SEPTIC SHOCK
• RECOMMENDATION is AGAINST using SOFA
SCORE compared to SIRS, NEWS or MEWS as a
single screening tool for shock/septic shock.
MEASUREMENT OF LACTATE
LEVELS
• It is SUGGESTED to measure blood lactate levels in
patients suspected for sepsis. (weak recommendation, low
quality evidence )

• Biomarker of tissue hypoxia and dysfunction, but not a direct


indicator of tissue perfusion.

• It is an evidence of cellular stress, also indicates refractory


hypotension.

• 1.6-2.5 mmol/L
INITIAL RESUSCITATION
• It is RECOMMENDED that treatment and resuscitation should
begin IMMEDIATELY in view of sepsis being a medical
emergency .(best clinical practice statement)

• For sepsis induced hypotension, it is SUGGESTED that ATLEAST


30 ML/KG IV FLUID CRYSTALLOID should be given within FIRST
3 HOURS OF RESUSCITATION. (weak recommendation, low
quality evidence)

• It is RECOMMENDED that DYNAMIC PARAMETERS -response to


passive leg raising or fluid bolus, SV, SVV, PPV, 2d echo, be used
as guide to resuscitation. (weak recommendation, low quality
evidence ) over physical examination/ static parameters alone.
• It is SUGGESTED to use DECREASING SERUM
LACTATE LEVELS in patients of sepsis/ septic shock as a
guide to resuscitation OVER NO SERUM LACTATE LEVEL
MONITORING. (weak recommendation, low quality
evidence )

• It is SUGGESTED to use CAPILLARY REFILL TIME as a


guide to PERFUSION AND RESUSCITATION as an adjunct
to other measures. (weak recommendation, low quality
evidence )
TARGET MEAN ARTERIAL PRESSURE
• It is RECOMMENDED that an initial TARGET
MEAN ARTERIAL PRESSURE (MAP) OF 65
MMHG must be maintained in patients of sepsis/
septic shock OVER HIGHER MEAN TARGETS
( strong recommendation, moderate quality
evidence
ADMISSION TO ICU
• It is SUGGESTED that patients with suspected
sepsis/ septic shock must be admitted to ICU
WITHIN INITIAL 6 HOURS.

• Outcomes of critically ill patients depend upon timely


application of critical care interventions in an appropriate
environment.
INFECTION
• It is RECOMMENDED to CONTINUOUSLY
EVALUATE AND SEARCH FOR ALTERNATIVE
DIAGNOSIS and DISCONTINUE EMPERICAL
ANTIMICROBIALS if alternate cause of illness is
STRONGLY SUSPECTED/ DIAGNOSED.
(Best clinical practice statement )
2021 GUIDELINES 2016 GUIDELINES
• It is RECOMMENDED to • It is RECOMMENDED to
administer antibiotics administer antibiotics
immediately, ideally within immediately, ideally within
1 HOUR OF 1 hour of recognition, In
RECOGNITION, In patients with BOTH
patients with possible SEPSIS AND SEPTIC
septic shock but NOT IN SHOCK (strong
SEPSIS WITHOUT recommendation,
SHOCK. (strong moderate quality evidence)
recommendation, low
quality evidence )
• In patients without septic shock, RAPID ASSESSMENT
of likelihood of INFECTIONS VERSUS NON
INFECTIOUS CAUSES of illness is RECOMMENDED.
(best clinical practice statement )

• In patients WITHOUT SEPTIC SHOCK, A time limited


course of RAPID INVESTIGATIONS (WITHIN 3
HOURS ) must be done, and if concern for infection
persists, then ADMINISTERING ANTIBIOTICS WITHIN
3 HOURS of first recognisisng sepsis is SUGGESTED.
(weak recommendation, very low quality of evidence)
BIOMARKERS TO START
ANTIBIOTICS
• It is SUGGESTED AGAINST using
PROCALCITONIN + CLINICAL EVALUATION to
decide when to start antimicrobials AS COMPARED
TO CLINICAL EVALUATION ALONE.
DECISION TO DEFER ANTIBIOTICS
2021 GUIDELINES 2016 GUIDELINES
• For adults with LOW • It is RECOMMENDED to
LIKELIHOOD OF INITIATE THE
INFECTION and ADMINISTRATION OF
WITHOUT SHOCK, it is ANTIMICROBIALS as
SUGGESTED to DEFER early as possible WITHIN
ANTIBIOTICS while 1 HOUR for patients in
continuiung to closely both sepsis and septic
monitor the patient. (weak shock.
recommendation, very low
quality evidence)
PATIENTS WITH POSSIBLE MRSA
INFECTION
2021 GUIDELINES 2016 GUIDELINES
It is RECOMMENDED to use • It is RECOMMENDED to use
EMPERICAL ANTIMICROBIALS EMPERICAL BROAD
WITH MRSA COVERAGE over SPECTRUM THERAPY WITH
using those without MRSA 1 OR MORE
coverage in patients with HIGH ANTIMICROBIALS TO COVER
RISK OF MRSA INFECTION. ALL LIKELY PATHOGENS
(best clinical practice statement ) ( including bacterial and
Similarly , it is RECOMMENDED potentially fungal or viral
AGAINST using emperical coverage) in patients of sepsis/
antimicrobials with MRSA septic shock . ( strong
coverage in patients with LOW recommendation, moderate
RISK OF MRSA. quality evidence )
MULTI DRUG RESISTANCE
ORGANISMS
• It is SUGGESTED to use 2 ANTIMICROBIALS WITH
GRAM NEGATIVE COVERAGE FOR EMPERICAL
TREATMENT OVER 1, in patients of sepsis with HIGH
RISK OF INFECTION WITH MULTIDRUG RESISTANT
(MDR) ORGANISMS. Similarly, it IS SUGGESTED
AGAINST using 2 antimicrobials in patients with low risk of
infections with MDR organisms.

• It is SUGGESTED AGAINST using double gram negative


coverage antibiotics ONCE THE CAUSATIVE AGENT IS
KNOWN.
ANTIFUNGAL THERAPY
2021 GUIDELINES 2016 GUIDELINES
• It is SUGGESTED to USE • It is RECOMMENDED to
EMPERICAL use EMPERICAL BROAD
ANTIFUNGAL THERAPY SPECTRUM THERAPY
OVER NO ANTIFUNGAL WITH 1 OR MORE
THERAPY in patients of ANTIMICROBIALS TO
sepsis/ septic shock with COVER ALL LIKELY
HIGH RISK OF FUNGAL PATHOGENS
INFECTIONS. ( weak ( INCLUDING BACTERIAL
recommendation, low AND POTENTIALLY
quality evidence ) FUNGAL OR VIRAL
COVERAGE)
CONT. CONT.
• It is SUGGESTED • patients of sepsis/ septic
AGAINST the use of shock .
antifungals in LOW RISK (strong recommendation,
OF FUNGAL INFECTION. moderate quality evidence)
(weak recommendation, low
quality evidence)
• No recommendation on use of ANTIVIRAL AGENTS.

• Prolonged INFUSION OF BETA LACTAMS FOR


MAINTAINENCE (AFTER INITIAL BOLUS ) OVER
CONVENTIONAL BOLUS INFUSION is SUGGESTED.
(strong recommendation, moderate quality evidence)

• OPTIMISING DOSING STRATEGIES of antimicrobials based


on ACCEPTED PHARMACOKINETIC/ PHARMACODYNAMIC
PRINCIPLES and specific drug properties is
RECOMMENDED. ( best clinical practice statement )
• It is RECOMMENDED to RAPIDLY IDENTIFY OR
EXCLUDE A SPECIFIC ANATOMICAL DIAGNOSIS OF
INFECTION THAT REQUIRES EMERGENT SOURCE
CONTROL and implementing any required SOURCE
CONTROL INTERVENTION as soon as medically and
logistically practical.( best clinical practice statement)

• PROMPT REMOVAL OF INTRAVASCULAR ACCESS


DEVICES that can be possible sources of infection after
other vascular access has been established is
RECOMMENDED . ( best clinical practice statement)
• DAILY ASSESSMENT FOR DE ESCALATION OF
ANTIMICROBIALS over using fixed durations of therapy
without daily assessment is SUGGESTED. (weak
recommendation, very low quality evidence)

• For patients with initial diagnosis of septic shock and


ADEQUATE SOURCE CONTROL, it is SUGGESTED to
use SHORTER DURATION OF ANTIMICROBIAL
THERAPY OVER LONGER.(weak recommendation, very
low quality evidence )
• It is SUGGESTED to use PROCALCITONIN
+CLINICAL EVALUATION to decide when to
DISCONTINUE ANTIMICROBIALS over CLINICAL
EVALUATION ALONE when optimal DURATION OF
THERAPY IS UNCLEAR.
(weak recommendation, low quality evidence )
HEMODYNAMIC MANAGEMENT
2021 GUIDELINES 2016 GUIDELINES
• It is RECOMMENDED to • It Is SUGGESTED to use
use BALANCED EITHER BALANCED
CRYSTALLOIDS for CRYSTALLOIDS OR
resuscitation OVER NORMAL SALINE FOR
NORMAL SALINE. RESUSCITATION.
(weak recommendation, low (weak recommendation, low
quality evidence ) quality evidence )
2021 GUIDELINES 2016 GUIDELINES
• It is SUGGESTED • It is SUGGESTED to use
AGAINST GELATIN USE CRYSTALLOIDS OVER
FOR RESUSCITATION OF GELATIN FOR
PATIENTS with RESUSCITATION of
sepsis/septic shock. (weak patients with sepsis/ septic
recommendation, shock. (weak
moderate quality evidence) recommendation, low
quality evidence )
• CRYSTALLOIDS to be used as 1ST LINE FLUID for
resuscitation is RECOMMENDED. (strong
recommendation, high quality evidence )

• It is RECOMMENDED to use ALBUMIN in patients who


have received LARGE VOLUMES OF CRYSTALLOIDS.
(weak recommendation, moderate quality evidence )

• RECOMMENDATION against using STARCHES FOR


RESUSCITATION. (strong recommendation, high quality
evidence )
• It is RECOMMENDED to use NOREPINEPHRINE as 1ST LINE
AGENT over other VASOPRESSORS. ( strong
recommendation, high quality evidence).
• Strong recommendations after norepinephrine in the order,
follow -
1. Dopamine ( high quality evidence ‘’)
2. Vasopressin (moderate ‘’)
3. Epinephrine (low ‘’ )
4. Selepressin (low’’ )
5. Angiotensin 2 (very low ‘’ )
• It is SUGGESTED to ADD VASOPRESSIN INSTEAD OF
ESCALATING NOR EPINEPHRINE dose in patients with
inadequate MAP. (weak recommendation ,moderate quality
evidence )

• It is SUGGESTED to add EPINEPHRINE OVER


VASOPRESSIN AND NOR EPINEPHRINE in patients not
maintaining MAP. (weak recommendation, low quality
evidence)

• It is SUGGESTED AGAINST use of TERLIPRESSIN.


(weak recommendation ,low quality of evidence )
• In patients with septic shock and CARDIAC
DYSFUNCTION, with PERSISTANT HYPOPERFUSION,
despite adequate volume status and arterial blood
pressure, It is SUGGESTED to add DOBUTAMINE to
norepinephrine or using epinephrine alone and
SUGGESTED AGAINST using LEVOSIMENDAN. (weak
recommendation ,low quality evidence )

• INVASIVE MONITORING of ARTERIAL BLOOD


PRESSURE over non invasive monitoring if feasable, is
SUGGESTED. (weak recommendation, very low quality
evidence )
• It is SUGGESTED to START VASOPRESSORS
PERIPHERALLY to restore mean arterial pressure
RATHER THAN DELAYING INITIATION until a central
venous access is restored. (weak recommendation, very
low quality evidence )

• There is INSUFFICIENT EVIDENCE to make a


recommendation on the use of restrictive versus liberal fluid
fluid strategies in the first 24 hours of resuscitation in
patients who still have signs of hypoperfusion and volume
depletion after initial resuscitation.
VENTILATION
• There is INSUFFICIENT EVIDENCE to make a
recommendation on use of conservative oxygen targets in
adults with sepsis induced hypoxemic respiratory failure.

• HIGH FLOW NASAL OXYGEN over non invasive


ventilation is SUGGESTED. (weak recommendation, low
quality evidence )

• INSUFFICIENT EVIDENCE to make a recommendation on


use of non invasive ventilation over invasive ventilation.
FOR PATIENTS WITH SEPSIS
INDUCED ARDS
• LOW TIDAL VOLUME (6ML/KG) ventilation strategy is recommended
over higher volumes(10ml/kg).
• Upper limit goal for PLATEAU PRESSURE is recommended to BE 30
CM H2O.
• It is suggested to use HIGHER PEEP OVER LOWER PEEP.
• TRADITIONAL RECRUITMENT MANEOUVERS are suggested.
• Recommendation against using INCREMENTAL PEEP STRATEGY.
• Prone ventilation for GREATER THAN 12 HOURS DAILY is
recommended.
• INTERMITTANT NMBA BOLUSES are suggested than using NMBA
CONTINUOUS INFUSION
• It is suggested to use VENO-VENOUS ECMO when
ADDITIONAL THERAPIES
2021 GUIDELINES 2016 GUIDELINES
• It is SUGGESTED to use • It is SUGGESTED against
IV CORTICOSTEROIDS in using INTRAVENOUS
patients of sepsis/ septic HYDROCORTISONE to
shock requiring treat septic shock patients
vasopressor therapy. if adequate fluid
(strong recommendation, resuscitation and
moderate quality vasopressor therapy are
evidence ) able to restore
hemodynamic stability.
2021 GUIDELINES 2016 GUIDELINES
• It is SUGGESTED against • If not achievable, then iv
using POLYMYXIN B HYDROCORTISONE
HEMOPERFUSION. 200MG/DAY is
( weak recommendation, RECOMMENDED.
low quality evidence ) • NO RECOMMENDATION
• INSUFFICIENT regarding use of BLOOD
EVIDENCE to make a PURIFICATION
recommendation on the TECHNIQUES
use of BLOOD
PURIFICATION
TECHNIQUES.
• RESTRICTIVE OVER LIBERAL TRANSFUSION strategy is
RECOMMENDED. (strong recommendation , moderate
quality evidence )
• It is SUGGESTED AGAINST using INTRAVENOUS
IMMUNOGLOBULINS. ( weak recommendation, low quality
evidence)
• It is SUGGESTED to use STRESS ULCER PROPHYLAXIS
in patients with RISK FACTORS FOR GIT BLEEDING.
(weak recommendation, moderate quality evidence )
• It is RECOMMENDED to USE PHARMACOLOGICAL
VENOUS THROMBOEMBOLISM PROPHYLAXIS unless a
contraindication to such therapy exists. (strong
recommendation, moderate quality evidence )
• It is RECOMMENDED to USE LOW MOLECULAR
WEIGHT HEPARIN OVER UNFRACTIONATED HEPARIN
for VTE prophylaxis. (strong recommendation, moderate
quality evidence )
• It is SUGGESTED AGAINST using MECHANICAL
THROMBOPROPHLAXIS + PHARMACOLOGICAL
THROMBOPROPHYLAXIS over pharmacological
thromboprophylaxis alone. (weak recommendation, low
quality evidence)
• It is SUGGESTED using RENAL REPLACEMENT THERAPY
(EITHER CONTINUOUS OR INTERMITTANT ) in patients of
sepsis/ septic shock with AKI . (weak recommendation, low
quality evidence )

• It is RECOMMENDED to initiate INSULIN THERAPY at a


glucose level of >180 MG/DL (10mmol/L) (strong
recommendation, moderate quality evidence )

• It is SUGGESTED AGAINST using INTRAVENOUS


VITAMIN C (weak recommendation, low quality evidence )
• For patients with septic shock and hypoperfusion induced lactic
acidemia, it is SUGGESTED AGAINST using SODIUM
BICARBONATE THERAPY TO IMPROVE HEMODYNAMICS or
to REDUCE VASOPRESSOR REQUIREMENTS (weak
recommendation ,low quality evidence)

• For patients with septic shock and SEVERE METABOLIC


ACIDEMIA PH<7.2 AND ACUTE KIDNEY INJURY use of
SODIUM BICARBONATE therapy is SUGGESTED. (weak
recommendation, low quality evidence )

• For patients with sepsis or septic shock who can be FED


ENTERALLY, EARLY INITIATION ( WITHIN 72 HOURS ) OF
ENTERAL NUTRITION is SUGGESTED. ( weak
recommendation, vey low quality evidence )
LONG TERM OUTCOMES AND
GOALS OF CARE
• DISCUSSING GOALS OF CARE EARLY (WITIN 72
HOURS ) AND PROGNOSIS with patients and families
over no such discussions/ late discussion is
RECOMMENDED. (best clinical practice statement)
• It is RECOMMENDED that PRINCIPLES OF PALLIATIVE
CARE should be incorporated into treatment plan. (best
clinical practice statement)
• SCREENING OF ECONOMIC AND SOCIAL SUPPORT
(housing, nutritional, financial, spiritual support) is
RECOMMENDED. (best clinical practice statement)
,
• RECONCILING MEDICATIONS at both ICU AND HOSPITAL
DISCHARGE is RECOMMENDED. (best clinical practice statement)

• INCLUSION OF INFORMATION ABOUT ICU STAY, SEPSIS,


RELATED DIAGNOSIS, TREATMENTS, AND COMMON
IMPAIRMENTS AFTER SEPSIS IN WRITEN AND VERBAL
HOSPITAL DISCHARGE SUMMARY are RECOMMENDED. (best
clinical practice statement)

• Patients who develped new impairments, it is RECOMMENDED


that HOSPITAL DISCHARGE PLANS INCLUDE FOLLOW UP WITH
CLINICIANS in order to support and manage new and long term
sequelae. (best clinical practice statement)
THANK
YOU

You might also like